Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited (EMCURE) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

arthbyemcure.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹1854.70
Market cap
35,177 Cr
Stock P/E
35.2
P/B
7.06
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales1,815 Cr2,002 Cr1,963 Cr2,116 Cr2,101 Cr2,270 Cr2,363 Cr2,470 Cr2,580 Cr
Operating expenses (approx.)1,479 Cr1,621 Cr1,608 Cr1,714 Cr1,684 Cr1,794 Cr1,871 Cr1,990 Cr2,048 Cr
EBITDA336 Cr381 Cr355 Cr402 Cr417 Cr475 Cr493 Cr480 Cr532 Cr
OPM %18.5%19.0%18.1%19.0%19.8%20.9%20.8%19.4%20.6%
Other income23 Cr36 Cr4 Cr4 Cr4 Cr3 Cr2 Cr4 Cr2 Cr
Interest59 Cr46 Cr32 Cr39 Cr27 Cr33 Cr38 Cr46 Cr32 Cr
Depreciation94 Cr97 Cr97 Cr97 Cr99 Cr105 Cr105 Cr106 Cr110 Cr
Profit before tax207 Cr273 Cr230 Cr261 Cr291 Cr341 Cr314 Cr341 Cr394 Cr
Tax %26.4%26.3%32.1%24.3%26.1%26.4%26.3%28.6%25.7%
Net profit153 Cr202 Cr156 Cr197 Cr215 Cr251 Cr231 Cr244 Cr292 Cr
EPS (₹)₹7.95₹10.33₹8.12₹9.97₹10.92₹12.85₹12.16₹12.84₹15.50

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025Mar 2026TTM
Sales7,896 Cr9,204 CrSign in for TTM
Operating expenses (approx.)6,422 Cr7,339 CrSign in for TTM
EBITDA1,474 Cr1,865 CrSign in for TTM
OPM %18.7%20.3%Sign in for TTM
Other income67 Cr13 CrSign in for TTM
Interest176 Cr144 CrSign in for TTM
Depreciation384 Cr415 CrSign in for TTM
Profit before tax971 Cr1,287 CrSign in for TTM
Tax %27.2%26.9%Sign in for TTM
Net profit707 Cr941 CrSign in for TTM
EPS (₹)₹36.43₹48.77Sign in for TTM
Dividend payout %0.0%6.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025Mar 2026
Equity capital189 Cr190 Cr
Reserves4,257 Cr4,760 Cr
Borrowings732 Cr1,204 Cr
Other liabilities2,859 Cr3,432 Cr
Total liabilities8,233 Cr9,612 Cr
Fixed assets (net)1,954 Cr1,960 Cr
CWIP124 Cr172 Cr
Investments95 Cr20 Cr
Inventories1,932 Cr2,398 Cr
Trade receivables2,002 Cr2,563 Cr
Cash & bank156 Cr137 Cr
Other assets1,970 Cr2,364 Cr
Total assets8,233 Cr9,612 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025Mar 2026
Cash from operating activity852 Cr944 Cr
Cash from investing-94 Cr-1,193 Cr
Cash from financing-814 Cr343 Cr
Net cash flow-58 Cr112 Cr
Free cash flow (OCF − Capex)445 Cr396 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025Mar 2026
ROCE %21.3%23.1%
ROE %14.7%18.6%
Debtor days92101
Inventory days461516
Days payable353389
Cash conversion cycle200228
Debt / equity0.160.24
Current ratio1.741.46
Net debt / EBITDA0.390.57

Compare with peers

Loading peers…